Fennec Pharmaceuticals Inc. (FENC)
NASDAQ: FENC · Real-Time Price · USD
6.71
-0.14 (-2.04%)
At close: Apr 28, 2026, 4:00 PM EDT
6.70
-0.01 (-0.15%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Fennec Pharmaceuticals Employees
Fennec Pharmaceuticals had 35 employees as of December 31, 2025. The number of employees increased by 3 or 9.38% compared to the previous year.
Employees
35
Change (1Y)
3
Growth (1Y)
9.38%
Revenue / Employee
$1,275,486
Profits / Employee
-$278,314
Market Cap
231.33M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Codexis | 146 |
| Voyager Therapeutics | 141 |
| Adagene | 128 |
| Heron Therapeutics | 128 |
| Arcturus Therapeutics Holdings | 111 |
| Orchestra BioMed Holdings | 86 |
| SAB Biotherapeutics | 86 |
| Camp4 Therapeutics | 48 |
FENC News
- 21 days ago - Fennec Pharmaceuticals Announces Investigator-Sponsored Study to Be Conducted by University of Arizona Cancer Center - GlobeNewsWire
- 4 weeks ago - Fennec Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 5 weeks ago - Fennec Pharmaceuticals Shareholders Are Encouraged to Reach Out to Johnson Fistel for More Information About Potentially Recovering Their Losses - Newsfile Corp
- 5 weeks ago - Fennec Pharmaceuticals Earnings Call Transcript: Q4 2025 - Transcripts
- 5 weeks ago - Fennec Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - GlobeNewsWire
- 5 weeks ago - Fennec Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call - Benzinga
- 5 weeks ago - Fennec Pharmaceuticals to Report Full Year and Fourth Quarter 2025 Financial Results on March 24, 2026 - GlobeNewsWire
- 7 weeks ago - Fennec Pharmaceuticals Announces Clinical Research Collaboration with Tampa General Hospital Cancer Institute - GlobeNewsWire